Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IDbyDNA raises $20mm in Series B round

Executive Summary

IDbyDNA Inc. (uses metagenomics to detect, identify, and interpret microorganisms) raised $20mm in its Series B financing led by ARTIS Ventures, which was joined by Genesys Capital and others. The company will use the proceeds to expand and commercialize its Explify platform for infectious disease and microbiome testing. Additional funds will support the opening of a CLIA-approved commercial laboratory in Salt Lake City.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies